Terms: = Lymphoma AND DNM2, CMTDI1, 1785, ENSG00000079805, DYNII, DYN2, CMTDIB AND Diagnosis
4 results:
1. Novel model predicts prognosis for patients with diffuse large B-cell lymphoma in first relapse after initial R-CHOP therapy: a single-institution study in China.
Wang W; Yin J; Zhang W; Zhang Y; Zhou D; Zhao D; Wei C
J Int Med Res; 2021 Apr; 49(4):3000605211002971. PubMed ID: 33845607
[TBL] [Abstract] [Full Text] [Related]
2. Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States.
Kabadi SM; Near A; Wada K; Burudpakdee C
Cancer Med; 2019 Dec; 8(17):7174-7185. PubMed ID: 31595715
[TBL] [Abstract] [Full Text] [Related]
3. Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
Ringdén O; Labopin M; Gorin NC; Schmitz N; Schaefer UW; Prentice HG; Bergmann L; Jouet JP; Mandelli F; Blaise D; Fouillard L; Frassoni F;
Br J Haematol; 2000 Dec; 111(4):1130-7. PubMed ID: 11167752
[TBL] [Abstract] [Full Text] [Related]
4. Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma.
Celsing F; Widell S; Merk K; Bernell P; Grimfors G; Hedlund A; Liliemark J; Svedmyr E; Osby E; Björkholm M
Ann Oncol; 1998 Nov; 9(11):1213-7. PubMed ID: 9862052
[TBL] [Abstract] [Full Text] [Related]
